Stay tuned
Amarin eyes blockbuster Vascepa sales as FDA grants heart-helping label expansion
Amarin has been on a scorching run with its fish-oil derivative Vasce
Jury orders Gilead's Kite Pharma to pay $752M for CAR-T patent infringement
In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers
Pfizer's Xeljanz gets convenience boost with new extended-release approval
It’s been a year of ups and downs for Pfizer’s Xeljanz. But the N
Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga
Eli Lilly and Boehringer Ingelheim's SGLT2 diabetes med Jardiance is
The House passed Pelosi's drug pricing bill, but don't expect it to become law
House Democrats passed Nancy Pelosi's drug pricing bill in a mostly p
Stay tuned
© 1994 - 2019 B.M. Pharmaceuticals